"This research may help in development of new types of small molecules and drugs that specifically modulate the signaling and trafficking processes," Cho said. "For example, if a cellular malfunction is caused by over-activation of a particular lipid-mediated pathway, then we can turn off that pathway by developing a compound that interferes with the interaction of the lipid with its binding protein."
| Contact: Paul Francuch francuch@uic.edu 312-996-3457 University of Illinois at Chicago Source:Eurekalert |